Abstract
Opportunistic mycoses burden is increasing globally in critically ill patient, which is even more evident in the developing countries. These mycoses constitute predominantly of invasive candidiasis but also of a sizeable number of invasive aspergillosis and invasive mucormycosis. Epidemiological studies from Asian subcontinent have highlighted the prevalence of these organisms in ICU and changing demographics of fungi which is peculiar to this part of the world. Increasing multidrug resistant fungi and increasing resistance to azoles has also been described in these studies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Vincent JL, Sakr Y, Sprung CL, Ranieri VM, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34:344–53.
Vincent JL, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302:2323–9.
Chakrabarti A, Sood P, Rudramurthy SM, et al. Incidence, characteristics and outcome of ICU-acquired candidemia in India. Intensive Care Med. 2015;41:285–95.
Kullberg BJ, Arendrup MC. Invasive candidiasis. N Engl J Med. 2015;373:1445–56.
Bassetti M, Righi E, Ansaldi F, et al. A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. Intensive Care Med. 2015;41:1601–10.
Hollenbach E. To treat or not to treat—critically ill patients with candiduria. Mycoses. 2008;51(suppl 2):12–24.
Bongomin F, Gago S, Oladele RO, Denning DW. Global and multi-National Prevalence of fungal diseases-estimate precision. J Fungi (Basel). 2017;3(4):57.
Playford EG, Marriott D, Nguyen Q, et al. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp. Crit Care Med. 2008;36:2034–9.
Chakrabarti A, Chatterjee SS, Rao KL, et al. Recent experience with fungaemia: change in species distribution and azole resistance. Scand J Infect Dis. 2009;41(4):275–84.
Chowdhary A, Sharma C, Meis JF. Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. PLoS Pathog. 2017;13(5):e1006290.
Ahmed A, Baronia AK, Azim A, Marak RS, Yadav R, Sharma P, et al. External validation of risk prediction scores for invasive candidiasis in a medical/surgical intensive care unit: an observational study. Indian J Crit Care Med. 2017;21:514–20.
Bansal N, Gopalakrishnan R, Sethuraman N, Ramakrishnan N, Nambi PS, Kumar DS, et al. Experience with β-D-glucan assay in the management of critically ill patients with high risk of invasive candidiasis: an observational study. Indian J Crit Care Med. 2018;22:364–8.
Liu W, Tan J, Sun J, et al. Invasive candidiasis in intensive care units in China: in vitro antifungal susceptibility in the China-SCAN study. J Antimicrob Chemother. 2014;69:162–7.
Sullivan KA, Caylor MM, Lin F-C, Campbell-Bright S. Comparison of amphotericin B bladder irrigations versus fluconazole for the treatment of candiduria in intensive care unit patients. J Pharm Pract. 2017;30:347–52.
Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62:e1–50.
Cornely OA, Bassetti M, Calandra T, et al. ESCMID guideline for the diagnosis and management of candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect. 2012;18(suppl 7):19–37.
Timsit JF, Azoulay E, Schwebel C, Charles PE, et al. Empirical micafungin treatment and survival without invasive fungal infection in adults with ICU-acquired Sepsis, Candida colonization, and multiple organ failure: the EMPIRICUS randomized clinical trial. JAMA. 2016;316(15):1555–64.
Lortholary O, Renaudat C, Sitbon K, et al. Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002–2010). Intensive Care Med. 2014;40:1303–12.
Baddley JW, Stephens JM, Ji X, Gao X, Schlamm HT, Tarallo M. Aspergillosis in intensive care unit (ICU) patients: epidemiology and economic outcomes. BMC Infect Dis. 2013;13:29.
Rudramurthy SM, Singh G, Hallur V, et al. High fungal spore burden with predomi- nance of Aspergillus in hospital air of a tertiary care hospital in Chandigarh. Indian J Med Microbiol. 2016;34:529–32.
He H, Ding L, Li F, Zhan Q. Clinical features of invasive bronchial-pulmonary aspergillosis in critically ill patients with chronic obstructive respiratory diseases: a prospective study. Crit Care. 2011;15:R5.
Crum-Cianflone NF. Invasive aspergillosis associated with severe influenza infections. Open Forum Infect Dis. 2016;3:71.
Chakrabarti A, Kaur H, Savio J, Rudramurthy SM. Atul Patel epidemiology and clinical outcomes of invasive mould infections in Indian intensive care units (FISF study). J Crit Care. 2019;51:64–70.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Todi, S. (2020). Mycoses in Intensive Care Units. In: Chakrabarti, A. (eds) Clinical Practice of Medical Mycology in Asia. Springer, Singapore. https://doi.org/10.1007/978-981-13-9459-1_5
Download citation
DOI: https://doi.org/10.1007/978-981-13-9459-1_5
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-9458-4
Online ISBN: 978-981-13-9459-1
eBook Packages: MedicineMedicine (R0)